Human Immunodeficiency Virus Infection

0
Pipeline Programs
1
Companies
0
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
Lopinavir / ritonavirN/ASmall Molecule
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)N/A

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

Small Molecule is the dominant modality (100% of programs)
1 companies competing in this space